injectable glp 1 agonists GLP-1 Agonists: A Comprehensive Overview GLP-1 Medications for Weight Loss
Description
Funding The authors have no funding for this project to declare
Fonseca VA, Devries JH, Henry RR, Donsmark M, Thomsen HF, Plutzky J
Although GLP-1 class medications have been on the market for 2 decades now, rarer serious side effects are now being seen more simply due to recent increases in the number of people on these medications3
Patients currently on semaglutide who have hit a weight loss plateau often see renewed progress when transitioning to tirzepatide, likely due to the additional GIP receptor activation
[PubMed] [Google Scholar] 31.Ussher JR, Drucker DJ
doi: 10.1016/S2213-8587(17)30312-1
